Hereditary tyrosinemia type 1 metabolites impair DNA excision repair pathways

Biochemical and Biophysical Research Communications

Volumn 401, Issue 1, 2010, Pages 32-36

  van Dyk, E ^a   Steenkamp, A ^a   Koekemoer, G ^a   Pretorius, P J ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Base excision repair; Comet assay; Hereditary tyrosinemia; Nucleotide excision repair

Indexed keywords

4 HYDROXYPHENYLPYRUVATE DIOXYGENASE; NUCLEIC ACID BASE; SUCCINYLACETONE;

ARTICLE; CELL STRAIN HEPG2; COMET ASSAY; CONTROLLED STUDY; EXCISION REPAIR; HEREDITARY TYROSINEMIA TYPE 1; HUMAN; HUMAN CELL; METABOLITE; PRIORITY JOURNAL; TYROSINEMIA;

CELL LINE; COMET ASSAY; DNA REPAIR; HEPTANOATES; HUMANS; HYDROGEN PEROXIDE; PHENYLPYRUVIC ACIDS; TYROSINEMIAS;

EID: 77957680987     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.002     Document Type: Article

References (23)

1. Scott C.R. The genetic tyrosinemias. Am. J. Med. Genet. C Semin. Med. Genet. 2006, 142C:121-126.
2. Dreumont N., Poudrier J.A., Bergeron A., Levy H.L., Baklouti F., Tanguay R.M. A missense mutation (Q279R) in the fumarylacetoacetate hydrolase gene responsible for hereditary tyrosinemia, acts as a splicing mutation. BMC Genet. 2001, 2:9-10.
3. K.S. Roth, Tyrosinemia, 2008 (2009). http://emedicine.medscape.com/article/949816-overview.
4. Mitchell G.A., Grompe M., Lambert M., Tanguay R.M. Hypertyrosinemia. The Metabolic and Molecular Bases of Inherited Disease 2001, 1777-1806. McGraw-Hill, New York. eighth ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
5. Prieto-Alamo M.J., Laval F. Deficient DNA-ligase activity in the metabolic disease tyrosinemia type I. Proc. Natl. Acad. Sci. USA 1998, 95:12614-12618.
6. Jorquera R., Tanguay R.M. Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability. Hum. Mol. Genet. 2001, 10:1741-1752.
7. Jorquera R., Tanguay R.M. Cyclin B-dependent kinase and caspase-1 activation precedes mitochondrial dysfunction in fumarylacetoacetate-induced apoptosis. FASEB J. 1999, 13:2284-2298.
8. van Dyk E., Pretorius P.J. DNA damage and repair in mammalian cells exposed to p-hydroxyphenylpyruvic acid. Biochem. Biophys. Res. Commun. 2005, 338:815-819.
9. Collins A.R., Dusinska M., Horvathova E., Munro E., Savio M., Stetina R. Inter-individual differences in repair of DNA base oxidation, measured in vitro with the comet assay. Mutagenesis 2001, 16:297-301.
10. Langie S.A., Knaapen A.M., Brauers K.J., van Berlo D., van Schooten F.J., Godschalk R.W. Development and validation of a modified comet assay to phenotypically assess nucleotide excision repair. Mutagenesis 2006, 21:153-158.
11. Mitra S., Izumi T., Boldogh I., Bhakat K.K., Hill J.W., Hazra T.K. Choreography of oxidative damage repair in mammalian genomes. Free Radic. Biol. Med. 2002, 33:15-28.
12. Mohrenweiser H.W., Wilson D.M., Jones I.M. Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat. Res. 2003, 526:93-125.
13. Christmann M., Tomicic M.T., Roos W.P., Kaina B. Mechanisms of human DNA repair: an update. Toxicology 2003, 193:3-34.
14. Plazar J., Hreljac I., Pirih P., Filipič M., Groothuis G.M.M. Detection of xenobiotic-induced DNA damage by the comet assay applied to human and rat precision-cut liver slices. Toxicol. in Vitro 2007, 21:1134-1142.
15. Brunner E., Dette H., Munk A. Box-type approximations in non-parametric factorial designs. J. Am. Stat. Assoc. 1997, 92:1494-1502.
16. Dunn O.J. Multiple comparisons using rank sums. Technometrics 1964, 6:241-252.
17. A. Dmitrienko, C. Chuang-Stein, R.B. D'Agostino, Pharmaceutical Statistics Using SAS: A Practical Guide. SAS Institute Inc., Cary, NC, 2007.
18. Cipollini M., He J., Rossi P., Baronti F., Micheli A., Rossi A.M., Barale R. Can individual repair kinetics of UVC-induced DNA damage in human lymphocytes be assessed through the comet assay?. Mutat. Res. 2006, 601:150-161.
19. Smith C.C., O'Donovan M.R., Martin E.A. hOGG1 recognizes oxidative damage using the comet assay with greater specificity than FPG or ENDOIII. Mutagenesis 2006, 21:185-190.
20. Wu M., Zhang Z., Che W. Suppression of a DNA base excision repair gene, hOGG1, increases bleomycin sensitivity of human lung cancer cell line. Toxicol. Appl. Pharm. 2008, 228:395-402.
21. Friedberg E.C., Walker G.C., Siede W., Wood R.D., Schultz R.A., Ellenberger T. DNA Repair and Mutagenesis 2006, ASM Press, Washington, DC. second ed.
22. Stang A., Witte I. The ability of the high-throughput comet assay to measure the sensitivity of five cell lines toward methyl methanesulfonate, hydrogen peroxide, and pentachlorophenol. Mutat. Res. 2010, 103-106.
23. Lundin C., North M., Erixon K., Walters K., Jenssen D., Goldman A.S.H., Helleday T. Methyl methanesulfonate (MMS) produces heat-labile DNA damage but no detectable in vivo DNA double-strand breaks. Nucleic Acids Res. 2005, 33:3799-3811.